ZT55
Product Specifications
CAS Number
2138488-38-5
Target
Others, Apoptosis, JAK
Related Pathways
JAK/STAT signaling, Angiogenesis, Stem Cells, Others, Apoptosis, Chromatin/Epigenetic, Tyrosine Kinase/Adaptors
Bioactivity
ZT55, an orally active, highly-selective JAK2 inhibitor with an IC50 of 0.031 μM, inhibits proliferation of JAK2 V617F-expressing HEL cell lines, induces apoptosis and cycle arrest, and effectively inhibits HEL xenograft tumor growth in mice models. Suitable for studies on myeloproliferative neoplasms, polycythemia vera, and primary thrombocythemia, ZT55 offers promising applications.
Smiles
C(C(NC1=C(OC)C=CC=C1)=O)C=2C=3C(N(O)C2)=CC=CC3
Molecular Formula
C17H16N2O3
Molecular Weight
296.32
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![3-[ (2-Morpholin-4-ylethyl) carbamoyl]benzeneboronic acid hydrochloride](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
sc-260619 250 mg
3-[ (2-Morpholin-4-ylethyl) carbamoyl]benzeneboronic acid hydrochloride
Sign In for Pricing
View Details 
MBS2098012-01 24 Strip Well
Human Fibroblast Growth Factor 20 (FGF20) ELISA Kit
Sign In for Pricing
View Details